-
Featured Authors
Archive
- June 2013 (1)
- May 2013 (3)
- April 2013 (5)
- March 2013 (2)
- February 2013 (4)
- January 2013 (1)
- December 2012 (2)
- November 2012 (3)
- October 2012 (3)
- September 2012 (3)
- August 2012 (5)
- July 2012 (4)
- June 2012 (7)
- May 2012 (5)
- April 2012 (3)
- March 2012 (4)
- February 2012 (6)
- January 2012 (2)
- December 2011 (2)
- November 2011 (3)
- October 2011 (3)
- September 2011 (5)
- August 2011 (4)
- July 2011 (8)
- June 2011 (16)
- May 2011 (8)
- April 2011 (9)
- March 2011 (14)
- February 2011 (9)
- January 2011 (15)
- December 2010 (7)
- November 2010 (6)
- October 2010 (4)
- June 2010 (1)
- May 2010 (4)
- April 2010 (14)
- March 2010 (4)
- January 2010 (5)
- November 2009 (3)
- October 2009 (1)
- August 2009 (6)
- July 2009 (9)
- June 2009 (9)
- May 2009 (8)
- April 2009 (9)
- March 2009 (9)
- February 2009 (3)
- January 2009 (1)
- November 2008 (1)
Category Archives: Patently BIOtech
BIO’s “What Every State Should Know About Bayh-Dole” Webinar
The Biotechnology Industry Organization (BIO) recently hosted a webinar entitled: “What Every State Should Know About Bayh-Dole: Leveraging University Research to Create Jobs and Spur Economic Development Benefits.” The Bayh-Dole Act, enacted in 1980, placed patent ownership of federally funded research at universities in the hands of the university and enabled universities to out-license technologies for commercialization. As a result of the Act, more than 7200 companies were created (including nearly 600 last year despite Read More >
Huffington Post: Data Exclusivity: Getting the Balance Right
Huffington Post: Data Exclusivity: Getting the Balance Right A great article on the downsides of cutting or removing data exclusivity provisions for biologics. The article points out that data protection is needed to enhance safety and create incentives to research and produce new innovative drugs that cost billions of dollars. However, the author argues that the period must be limited somehow (not 50 years) to ensure generics can entire the market and lower costs. Finally, the author states that lowering the data exclusivity Read More >
Chairman Bernanke’s Speach on Government R&D Spending Policy and Economic Development
FED Chairman Ben Bernanke spoke about government funding of research and development at Georgetown University for the “New Building Blocks for Jobs and Economic Growth” conference. Highlights relating to Intellectual Property: 1. “Economic policy affects innovation and long-run economic growth in many ways. A stable macroeconomic environment; sound public finances; and well-functioning financial, labor, and product markets all support innovation, entrepreneurship, and growth, as do effective tax, trade, and regulatory policies. Policies directed at objectives such as the Read More >
Battelle Report: $3.8 Billion Investment in Human Genome Project Drove $796 Billion in Economic Impact Creating 310,000 Jobs and Launching the Genomic Revolution
Battelle study reports the success of the Human Genome Project. Technology Transfer at its best. $3.8 BILLION INVESTMENT IN HUMAN GENOME PROJECT DROVE $796 BILLION IN ECONOMIC IMPACT CREATING 310,000 JOBS AND LAUNCHING THE GENOMIC REVOLUTION “Genomic Revolution” Forging Major Breakthroughs in Medicine, Agriculture, Security & Justice, and Energy and Promises to Create Significantly More Jobs in the Future WASHINGTON, D.C. — The $3.8 billion the U.S. government invested in the Human Genome Project (HGP) from 1988 Read More >
